{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:33:16Z","timestamp":1791264796294,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cyto.2023.156267","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T05:48:16Z","timestamp":1686635296000},"page":"156267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis"],"prefix":"10.1016","volume":"169","author":[{"given":"Qingkai","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA. Cancer. J. Clin."},{"key":"10.1016\/j.cyto.2023.156267_b0010","doi-asserted-by":"crossref","unstructured":"A.M. Hughes, V. Kuek, R.S. Kotecha, L.C. Cheung, The Bone Marrow Microenvironment in B-Cell Development and Malignancy, Cancers (Basel). 14(9) (2022) 2089.","DOI":"10.3390\/cancers14092089"},{"issue":"47","key":"10.1016\/j.cyto.2023.156267_b0015","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/sj.onc.1210758","article-title":"Aberrant cytokine signaling in leukemia","volume":"26","author":"Van Etten","year":"2007","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia."},{"issue":"5","key":"10.1016\/j.cyto.2023.156267_b0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri3132","article-title":"The bone marrow at the crossroads of blood and immunity","volume":"12","author":"Mercier","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156267_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer."},{"issue":"13","key":"10.1016\/j.cyto.2023.156267_b0040","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.3390\/ijms22136888","article-title":"Therapeutic Targeting of the Leukaemia Microenvironment","volume":"22","author":"Kuek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0045","first-page":"229","article-title":"Evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute lymphoblastic leukemia using biochip array technology","volume":"35","author":"Horacek","year":"2013","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.cyto.2023.156267_b0050","doi-asserted-by":"crossref","first-page":"5530650","DOI":"10.1155\/2021\/5530650","article-title":"Imbalance of Chemokines and Cytokines in the Bone Marrow Microenvironment of Children with B-Cell Acute Lymphoblastic Leukemia","volume":"2021","author":"Magalh\u00e3es-Gama","year":"2021","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-016-0894-9","article-title":"Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling","volume":"14","author":"Bi","year":"2016","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.cyto.2023.156267_b0060","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.3892\/or.2016.4657","article-title":"Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection","volume":"35","author":"P\u00e9rez-Figueroa","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2(Suppl.)","key":"10.1016\/j.cyto.2023.156267_b0065","first-page":"619","article-title":"Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance","volume":"30","author":"Xiang","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbamcr.2015.08.015","article-title":"Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting","volume":"1863","author":"Chiarini","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cyto.2005.07.009","article-title":"Cytometric bead array (CBA) for the measurement of cytokines in urine and plasma of patients undergoing renal rejection","volume":"32","author":"Jim\u00e9nez","year":"2005","journal-title":"Cytokine."},{"key":"10.1016\/j.cyto.2023.156267_b0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.5604\/17322693.1064009","article-title":"The usefulness of flow cytometric analysis of cytokines in peripheral blood and bone marrow plasma","volume":"67","author":"Stelmaszczyk-Emmel","year":"2013","journal-title":"Postepy. Hig. Med. Dosw (Online)"},{"issue":"6 Pt 1","key":"10.1016\/j.cyto.2023.156267_b0085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1373\/49.6.1000","article-title":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum","volume":"49","author":"T\u00e1rnok","year":"2003","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2023.156267_b0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1042\/BST20180136","article-title":"The role of the interleukin (IL)-6\/IL-6 receptor axis in cancer","volume":"46","author":"Taher","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cyto.2023.156267_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","article-title":"The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators","volume":"43","author":"Binder","year":"2018","journal-title":"Cytokine. Growth. Factor. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hon.725","article-title":"Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy","volume":"22","author":"Mazur","year":"2004","journal-title":"Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156267_b0110","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.12237","article-title":"Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia","volume":"142","author":"Bhattacharya","year":"2014","journal-title":"Immunology."},{"issue":"2","key":"10.1016\/j.cyto.2023.156267_b0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1378\/chest.117.2.365","article-title":"Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients","volume":"117","author":"De Vita","year":"2000","journal-title":"Chest."},{"issue":"12","key":"10.1016\/j.cyto.2023.156267_b0125","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1177\/0300060518800588","article-title":"Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer","volume":"46","author":"Feng","year":"2018","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0130","first-page":"713","article-title":"Predictive value of IL-18 and IL-10 in the prognosis of patients with colorectal cancer","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1081\/CNV-100102550","article-title":"Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"Cancer. Invest."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/eos.12131","article-title":"Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications","volume":"122","author":"Wang","year":"2014","journal-title":"Eur. J. Oral. Sci."},{"key":"10.1016\/j.cyto.2023.156267_b0145","doi-asserted-by":"crossref","unstructured":"H. Zhang, R. Li, Y. Cao, Y. Gu, C. Lin, X. Liu, K. Lv, X. He, H. Fang, K. Jin, Y. Fei, Y. Chen, J. Wang, H. Liu, H. Li, H. Zhang, H. He, W. Zhang, Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients, Ann. Surg. 275(4) (2022) e626-e635.","DOI":"10.1097\/SLA.0000000000004037"},{"key":"10.1016\/j.cyto.2023.156267_b0150","doi-asserted-by":"crossref","unstructured":"K. Zhang, X. Li, R. Huang, C. Chen, W. Hu, IL-10 as an Indicator for Predicting Clinical Progression in Acute Lymphoblastic Leukemia Patients, Clin. Lab. 67(10) (2021) :10.7754\/Clin.Lab.2021.210122.","DOI":"10.7754\/Clin.Lab.2021.210122"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156267_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11693-015-9161-2","article-title":"TGF-\u03b2 signaling and its role in the regulation of hematopoietic stem cells","volume":"9","author":"Vaidya","year":"2015","journal-title":"Syst. Synth. Biol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156267_b0160","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","article-title":"Role of transforming growth factor-beta in hematologic malignancies","volume":"107","author":"Dong","year":"2006","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.cyto.2023.156267_b0165","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","article-title":"Role of transforming growth factor Beta in human cancer","volume":"23","author":"Elliott","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"6688","key":"10.1016\/j.cyto.2023.156267_b0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/27945","article-title":"The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3","volume":"394","author":"Kurokawa","year":"1998","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.cyto.2023.156267_b0175","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood.V97.7.2137","article-title":"Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein\/p300","volume":"97","author":"Mori","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.cyto.2023.156267_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2020.05.002","article-title":"Regulation of CD4+CD25+FOXP3+ cells in Pediatric Acute Lymphoblastic Leukemia (ALL): Implication of cytokines and miRNAs","volume":"124","author":"El-Maadawy","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2023.156267_b0185","doi-asserted-by":"crossref","unstructured":"B. Sanchez-Correa, J.M. Bergua, C. Campos, I. Gayoso, M.J. Arcos, H. Ba\u00f1as, S. Morgado, J.G. Casado, R. Solana, R. Tarazona R, Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels, Cytokine. 61(3) (2013) 885-891.","DOI":"10.1016\/j.cyto.2012.12.023"},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/10428194.2011.603446","article-title":"Reduction of transforming growth factor-\u03b21 expression in leukemia and its possible role in leukemia development","volume":"53","author":"Wu","year":"2012","journal-title":"Leuk. Lymphoma."},{"issue":"6","key":"10.1016\/j.cyto.2023.156267_b0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031197","article-title":"Loss of Smad3 in acute T-cell lymphoblastic leukemia","volume":"351","author":"Wolfraim","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cyto.2023.156267_b0200","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/cas.12459","article-title":"Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia","volume":"105","author":"Han","year":"2014","journal-title":"Cancer. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2023.156267_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2012.09.007","article-title":"Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date","volume":"148","author":"Hemdan","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2023.156267_b0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","article-title":"The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin","volume":"8","author":"Weaver","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cyto.2023.156267_b0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jep.2015.01.016","article-title":"Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17\/Treg imbalance in the murine ovalbumin asthma model","volume":"164","author":"Wei","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156267_b0220","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/154405910708600409","article-title":"MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis","volume":"86","author":"Beklen","year":"2007","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.cyto.2023.156267_b0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0083-6729(06)74010-9","article-title":"The IL-17 cytokine family","volume":"74","author":"Gaffen","year":"2006","journal-title":"Vitam. Horm."},{"issue":"4","key":"10.1016\/j.cyto.2023.156267_b0230","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 Family of Cytokines in Health and Disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.cyto.2023.156267_b0235","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12032-013-0732-3","article-title":"Prognostic value of Th17 cells in acute leukemia","volume":"30","author":"Abousamra","year":"2013","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156267_b0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(94)90332-8","article-title":"Lymphocyte responses and cytokines","volume":"76","author":"Paul","year":"1994","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.cyto.2023.156267_b0245","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1073\/pnas.0400339101","article-title":"Interleukin 2 plays a central role in Th2 differentiation","volume":"101","author":"Cote-Sierra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.cyto.2023.156267_b0250","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.1656","article-title":"Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression","volume":"9","author":"Liao","year":"2008","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156267_b0255","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(03)00292-9","article-title":"Stat5 activation plays a critical role in Th2 differentiation","volume":"19","author":"Zhu","year":"2003","journal-title":"Immunity."},{"issue":"5107","key":"10.1016\/j.cyto.2023.156267_b0260","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science."},{"key":"10.1016\/j.cyto.2023.156267_b0265","doi-asserted-by":"crossref","unstructured":"D. Novick, S.H. Kim, G. Fantuzzi G, L.L. Reznikov, C.A. Dinarello, M. Rubinstein, Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response, Immunity. 10(1) (1999) 127-136.","DOI":"10.1016\/S1074-7613(00)80013-8"},{"issue":"4","key":"10.1016\/j.cyto.2023.156267_b0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1471-4906(03)00067-X","article-title":"Novel IL-12 family members shed light on the orchestration of Th1 responses","volume":"24","author":"Brombacher","year":"2003","journal-title":"Trends. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156267_b0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/cancers13020167","article-title":"IL-12 Family Cytokines in Cancer and Immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6587","key":"10.1016\/j.cyto.2023.156267_b0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/382171a0","article-title":"Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells","volume":"382","author":"Thierfelder","year":"1996","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.cyto.2023.156267_b0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1074-7613(03)00057-8","article-title":"GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet","volume":"18","author":"Usui","year":"2003","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.cyto.2023.156267_b0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production","volume":"2","author":"Yang","year":"2001","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156267_b0295","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer. Res."},{"key":"10.1016\/j.cyto.2023.156267_b0300","doi-asserted-by":"crossref","unstructured":"H. Ubukata, G. Motohashi, T. Tabuchi, H. Nagata, S. Konishi, T. Tabuchi T, Evaluations of interferon-\u03b3\/interleukin-4 ratio and neutrophil\/lymphocyte ratio as prognostic indicators in gastric cancer patients, J. Surg. Oncol. 102(7) (2010) 742-747.","DOI":"10.1002\/jso.21725"},{"issue":"10","key":"10.1016\/j.cyto.2023.156267_b0305","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","article-title":"Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma","volume":"80","author":"Yang","year":"2020","journal-title":"Cancer. Res."},{"issue":"15","key":"10.1016\/j.cyto.2023.156267_b0310","doi-asserted-by":"crossref","first-page":"e25548","DOI":"10.1097\/MD.0000000000025548","article-title":"Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia","volume":"100","author":"Dai","year":"2021","journal-title":"Medicine (Baltimore)."},{"issue":"7","key":"10.1016\/j.cyto.2023.156267_b0315","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPH.0000000000000417","article-title":"Fever at Diagnosis of Pediatric Acute Lymphoblastic Leukemia: Are Antibiotics Really Necessary?","volume":"37","author":"Khurana","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2023.156267_b0320","doi-asserted-by":"crossref","unstructured":"M.G. Netea, B.J. Kullberg, J.W. Van der Meer, Circulating cytokines as mediators of fever, Clin. Infect. Dis. 31 Suppl 5 (2000) S178-S184.","DOI":"10.1086\/317513"},{"issue":"1","key":"10.1016\/j.cyto.2023.156267_b0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12032-008-9081-z","article-title":"Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients","volume":"26","author":"Buyukberber","year":"2009","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156267_b0330","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1986.4.9.1380","article-title":"Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease","volume":"4","author":"Atkins","year":"1986","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156267_b0335","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO;2-Z","article-title":"Clinical effects and toxicity of interleukin-2 in patients with cancer","volume":"58","author":"Lotze","year":"1986","journal-title":"Cancer."},{"issue":"6","key":"10.1016\/j.cyto.2023.156267_b0340","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00916947","article-title":"Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients","volume":"8","author":"Mier","year":"1988","journal-title":"J. Clin. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662300145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662300145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:29:48Z","timestamp":1778581788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662300145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"alternative-id":["S104346662300145X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156267","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156267"}}